Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials

Shah, V, Johnson, DC, Sherborne, AL et al. (18 more authors) (2018) Characterisation of Long-Term Responders to First-Line Myeloma Therapy - Results from the UK Myeloma IX and XI Trials. In: Blood. 60th ASH Annual Meeting, 01-04 Dec 2018, San Diego, California, USA. American Society of Hematology, p. 2000. ISSN: 0006-4971 EISSN: 1528-0020

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Keywords: multiple myeloma, lenalidomide, thalidomide, transplantation, bortezomib, cardiovascular diseases, follow-up, genetic aspects, magnetic resonance cholangiography, neoadjuvant therapy
Dates:
  • Published: 29 November 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 05 May 2020 11:22
Last Modified: 29 Jun 2020 13:36
Status: Published
Publisher: American Society of Hematology
Identification Number: 10.1182/blood-2018-99-110149
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)